Clinical trial to compare the efficacy and safety between the combination of dorzolamide hydrochloride (2%) + brimonidine tartrate (0.2%) + timolol maleate (0.5%) and COMBIGAN® (combination of 0.2% brimonidine tartrate + 0.5% timolol maleate) in reducing ocular pressure in adult patients with primary open-angle glaucoma or high pressure in the eyes
Active, not recruitingRBR-3crsfj
Laboratório Daudt Oliveira Ltda.Primary open-angle glaucoma
Start: 2020-06-01Updated: 2025-10-27